Results 191 to 200 of about 1,191,211 (370)

Effect of an app for promoting advance care planning and motivating patients to write their advance directives. [PDF]

BMC Health Serv Res, 2023
Schöpfer C, Bollondi C, Moussa MA, Sommer J, Clavien C.   +4 more
europepmc   +1 more source

Differences in Presenting Advance Directives in the Chart, in the Minimum Data Set, and Through the Staffs Perceptions [PDF]

, 2003
Jiska Cohen‐Mansfield, Alexander Libin, S. Lipson   +2 more
openalex   +1 more source

Evaluation of KRAS and NRAS mutations in metastatic colorectal cancer: an 8‐year study of 10 754 patients in Turkey

Molecular Oncology, EarlyView.
This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci, Izzet Akiva, Yavuz Hakan Ozon, Hakan Berkil, Huseyin Karadayi, Omer Dizdar, Suayib Yalcin   +6 more
wiley   +1 more source

Associations of health literacy, personality traits, and pro-individualism with the willingness to complete advance directives in Taiwan. [PDF]

BMC Palliat Care, 2023
Chen DR, Weng HC.
europepmc   +1 more source

Landscape of BRAF transcript variants in human cancer

Molecular Oncology, EarlyView.
We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda, Danilo Tatoni, Gianluca Mattei, Alberto Magi, Romina D'Aurizio, Laura Poliseno   +5 more
wiley   +1 more source

Advance directives in mental health [PDF]

, 2003
Jacqueline M. Atkinson, Helen C Garner
openalex   +1 more source

Loss of proton‐sensing GPR4 reduces tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
G protein‐coupled receptor 4 (GPR4) is a pH‐sensing receptor activated by acidic pH. GPR4 expression is increased in patients with inflammatory bowel disease who are at high risk of developing colorectal cancer. In mouse models, loss of GPR4 attenuated tumor progression. This correlated with increased IL2 and natural killer cell activity.
Leonie Perren, Moana Busch, Pedro A. Ruiz, Ermanno Malagola, Valeria Baumeler, Federica Foti, Adelina Gross, Tobias Grütter, Hendrik Edel, Cordelia Schuler, Kristina Handler, Glenn De Lange, Isabelle C. Arnold, Cheryl de Vallière, Klaus Seuwen, Martin Hausmann, Gerhard Rogler   +16 more
wiley   +1 more source

Facilitated Psychiatric Advance Directives: A Randomized Trial of an Intervention to Foster Advance Treatment Planning Among Persons with Severe Mental Illness [PDF]

, 2006
Jeffrey W. Swanson
openalex   +2 more sources

Preparing for the end-of-life: public attitudes towards advance directives and assisted suicide in Switzerland. [PDF]

BMC Palliat Care
Blanc S, Meier C, Gamondi C, Maurer J, Jox RJ.   +4 more
europepmc   +1 more source

Adherence to advance directives: Advance directive needs to include additional elements [PDF]

, 2003
Geoff Knox
openalex   +1 more source